{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:27:11Z","timestamp":1792553231107,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31501097"],"award-info":[{"award-number":["31501097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB1046"],"award-info":[{"award-number":["2023AFB1046"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011491","name":"Bureau of Science and Technology of Zhoushan","doi-asserted-by":"publisher","award":["2023020201020519"],"award-info":[{"award-number":["2023020201020519"]}],"id":[{"id":"10.13039\/501100011491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bbrc.2023.149244","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T19:30:51Z","timestamp":1700249451000},"page":"149244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Bioinformatics and experimental studies jointly reveal that Sacubitril Valsartan improves myocardial oxidative stress and inflammation by regulating the MAPK signaling pathway to treat chemotherapy related cardiotoxicity"],"prefix":"10.1016","volume":"690","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-4733","authenticated-orcid":false,"given":"Hongwei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5306-9084","authenticated-orcid":false,"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.149244_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2023.149244_bib2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"An update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2023.149244_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102089","article-title":"Role of acetylation in doxorubicin-induced cardiotoxicity","volume":"46","author":"Li","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbrc.2023.149244_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10549-021-06280-x","article-title":"Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies","volume":"188","author":"Dempsey","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2023.149244_bib5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1042\/CS20210059","article-title":"Cancer therapy-related cardiac dysfunction: is endothelial dysfunction at the heart of the matter?","volume":"135","author":"Ching","year":"2021","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbrc.2023.149244_bib6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.1049","article-title":"Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience","volume":"20","author":"Fornaro","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbrc.2023.149244_bib7","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2023.149244_bib8","first-page":"309","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2023.149244_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7872193","article-title":"RING finger protein 10 regulates AP-1\/meox2 to mediate pirarubicin-induced cardiomyocyte apoptosis","volume":"2023","author":"Shi","year":"2023","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2023.149244_bib10","article-title":"Schisandrin B antagonizes cardiotoxicity induced by pirarubicin by inhibiting mitochondrial permeability transition pore (mPTP) opening and decreasing cardiomyocyte apoptosis","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.149244_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamacardio.2016.3053","article-title":"Angiotensin neprilysin inhibition for patients with heart failure: what if sacubitril\/valsartan were a treatment for cancer?","volume":"1","author":"Packer","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bbrc.2023.149244_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"Mcmurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2023.149244_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012272","article-title":"Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis","volume":"8","author":"Wang","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbrc.2023.149244_bib14","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ejhf.580","article-title":"Efficacy of sacubitril\/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial","volume":"18","author":"Vardeny","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbrc.2023.149244_bib15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbrc.2023.149244_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2018.01.077","article-title":"Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction","volume":"258","author":"Kompa","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2023.149244_bib17","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2217\/nnm-2018-0054","article-title":"p38 siRNA-encapsulated PLGA nanoparticles alleviate neuropathic pain behavior in rats by inhibiting microglia activation","volume":"13","author":"Shin","year":"2018","journal-title":"Nanomedicine (London, England)"},{"key":"10.1016\/j.bbrc.2023.149244_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.diabres.2018.06.020","article-title":"LncRNA MALAT1 promotes the apoptosis and oxidative stress of human lens epithelial cells via p38MAPK pathway in diabetic cataract","volume":"144","author":"Gong","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2023.149244_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2015.07.013","article-title":"Modulation of p38 kinase by DUSP4 is important in regulating cardiovascular function under oxidative stress","volume":"89","author":"Barajas-Espinosa","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2023.149244_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2018.01.017","article-title":"Monocyte dysfunction induced by low density lipoprotein occurs via a DUSP-1\/p38 MAPK signaling impairment","volume":"255","author":"Picozza","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2023.149244_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197412","article-title":"p38 MAPK pathway in the heart: new insights in health and disease","volume":"21","author":"Romero-Becerra","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.149244_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101636","article-title":"Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK\/macrophage\/Fizz3 axis in mice","volume":"36","author":"Ye","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbrc.2023.149244_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785","article-title":"Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbrc.2023.149244_bib24","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/cvr\/cvab209","article-title":"Non-invasive transcutaneous vagal nerve stimulation improves myocardial performance in doxorubicin-induced cardiotoxicity","volume":"118","author":"Lai","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2023.149244_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1078-0432.CCR-17-1117","article-title":"Tumor-treating fields: a fourth modality in cancer treatment","volume":"24","author":"Mun","year":"2018","journal-title":"Clin. Cancer Res. : Off. J.Am. Assoc. Cancer Res."},{"key":"10.1016\/j.bbrc.2023.149244_bib26","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.7150\/thno.72559","article-title":"Calixarene-modified albumin for stoichiometric delivery of multiple drugs in combination-chemotherapy","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2023.149244_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102120","article-title":"Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells","volume":"46","author":"Pan","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbrc.2023.149244_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2021.03.018","article-title":"Long non-coding RNAs in the doxorubicin resistance of cancer cells","volume":"508","author":"Ashrafizaveh","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2023.149244_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179283","article-title":"Doxorubicin-induced autophagolysosome formation is partly prevented by mitochondrial ROS elimination in DOX-resistant breast cancer cells","volume":"22","author":"Ahmadpour","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.149244_bib30","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.7150\/ijbs.58786","article-title":"Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity","volume":"17","author":"Tian","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2023.149244_bib31","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1161\/CIRCRESAHA.109.213199","article-title":"MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart","volume":"106","author":"Streicher","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2023.149244_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-016-2838-3","article-title":"MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy","volume":"424","author":"Singh","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2023.149244_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.lfs.2018.05.051","article-title":"Exogenous hydrogen sulfide ameliorates high glucose-induced myocardial injury & inflammation via the CIRP-MAPK signaling pathway in H9c2 cardiac cells","volume":"208","author":"Zhao","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2023.149244_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.intimp.2017.01.029","article-title":"MicroRNA-135a is up-regulated and aggravates myocardial depression in sepsis via regulating p38 MAPK\/NF-\u03baB pathway","volume":"45","author":"Zheng","year":"2017","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.bbrc.2023.149244_bib35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","article-title":"Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway","volume":"97","author":"Geng","year":"2018","journal-title":"Biomed. Pharmacother.= Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2023.149244_bib36","article-title":"Baicalein ameliorates myocardial ischemia through reduction of oxidative stress, inflammation and apoptosis via TLR4\/MyD88\/MAPK(S)\/NF-\u03baB pathway and regulation of Ca(2+) homeostasis by L-type Ca(2+) channels","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.149244_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101957","article-title":"DDIT4 S-nitrosylation aids p38-MAPK signaling complex assembly to promote hepatic reactive oxygen species production","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23013384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23013384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:49:56Z","timestamp":1762094996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23013384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":37,"alternative-id":["S0006291X23013384"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.149244","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioinformatics and experimental studies jointly reveal that Sacubitril Valsartan improves myocardial oxidative stress and inflammation by regulating the MAPK signaling pathway to treat chemotherapy related cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.149244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"149244"}}